Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of
the population worldwide. The disease is characterized by the selective loss of melanocytes …

Vitiligo is an acquired chronic depigmenting disorder of the skin, with an estimated
prevalence of 0.5% of the general population, characterized by the development of white …

Vitiligo is an acquired dyschromia of the skin in which there is a loss of epidermal
melanocytes. The prevalence of vitiligo is approximately 1% in the United States and 0.1-2 …

Vitiligo is an acquired pigmentry disorder of the skin and mucous membranes which
manifests as white macules and patches due to selective loss of melanocytes. Etiological …

Vitiligo is a common depigmenting skin disorder, characterized by acquired, idiopathic,
progressive, circumscribed hypomelanosis of the skin and hair, with total absence of …

Vitiligo is an acquired, chronic condition characterised by depigmentation of the epidermis
or by destruction/loss of melanin. Skin cells (melanocytes) are responsible for producing …

Vitiligo is an acquired pigmentary disorder of unknown etiology that is clinically
characterized by the development of white macules related to the selective loss of …

Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are
safe and effective treatments available for vitiligo. It is important to recognize common and …

The pathophysiology of vitiligo is becoming increasingly clarified. In non-segmental vitiligo,
early factors include activation of innate immunity, inflammasome activation, oxidative stress …

Summary During the 2011 International Pigment Cell Conference (IPCC), the Vitiligo
European Taskforce (VETF) convened a consensus conference on issues of global …